Clinical trialNCT03632135CompletedPhase 3Interventional

Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma

SponsorCordgenics, LLCEnrollment78Recurrent Glioblastoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this clinical study is to confirm the utility of chemosensitivity tumor testing on cancer stem cells (ChemoID) as a predictor of clinical response in poor prognosis malignant brain tumors such as recurrent glioblastoma (GBM).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Tulika Ranjan, MD
Allegheny Health Network
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Kaiser Permanente
Los Angeles, California, United States
Keck School of Medicine of the University of Southern California
Los Angeles, California, United States
Louisiana State University Health Sciences Center
New Orleans, Louisiana, United States
Maine Medical Center Research Institute
Scarborough, Maine, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
University of Cincinnati Cancer Institute
Cincinnati, Ohio, United States
Toledo University
Toledo, Ohio, United States
Providence Cancer Center Oncology
Portland, Oregon, United States
St. Luke'S University Health Network
Bethlehem, Pennsylvania, United States
the Penn State Univeristy College of Medicine
Hershey, Pennsylvania, United States
Thomas Jefferson University Hospitals
Philadelphia, Pennsylvania, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Charleston Area Medical Center
Charleston, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Chemotherapy →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 May 2018
Primary completion: 16 Jun 2022
Completion: 31 Dec 2023
Last update posted: 15 Apr 2025
Registered enrollment: 78
Registry id: NCT03632135

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.